CureVac ( ($CVAC) ) just unveiled an update. On January 6, 2026, CureVac N.V. completed a post-offer reorganization tied to BioNTech SE’s exchange ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) announced the closing of its acquisition of CureVac N.V. (NASDAQ:CVAC), which ...

BioNTech SE (NASDAQ:BNTX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, Clear Street analysts reiterated a Buy rating on BioNTech SE (NASDAQ:BNTX), buoyed ...

The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial ...

In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts. The biotech sector has been a disaster for investors over the past five years going by a 14% ...

BioNTech's financial results provide a baseline for the enlarged entity post-CureVac integration. In the third quarter of 2025, the company generated approximately €1.5 billion in revenue and ...

With the merger's completion on January 6, 2026, CureVac's era on the public markets will end. The focus will shift entirely to integrating its clinical candidates, particularly in cancer ...

In this article, we will look at the 10 Stocks That Will Go To The Moon in 2026. 2026 is said to be an inflection point in the AI trade. To discuss this, Dan Ives, Wedbush Securities, joined CNBC ...

ATLANTA, GA - December 15, 2025 ( NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced the ...

Detailed price information for Neurocrine Bioscienc (NBIX-Q) from The Globe and Mail including charting and trades.

Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists ...